PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12382740::ACT024005

CAP-18_31

Evidence text

Paper-level observation

Table 4: CAP-18_31 hemolysis IC50 185.26 uM against human erythrocytes
tableConfidence: medium

Assay observation

Activity
Toxicity
Subtype
Hemolytic
Measure
other
Comparator
=
Raw observation
185.26 µM
Normalized measurement
=185.26 µM
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKL
Standardization
ready simple

Source publication

In Vitro and In Vivo Characterization of Novel Cathelicidin-Based Peptides with Antimicrobial Activity Against Pseudomonas aeruginosa

Antibiotics · 2025

DOI 10.3390/antibiotics14080838 PMC12382740
Parent mention

Related peptide identities

PEPDIA-PLP-001033

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.